Search

Your search keyword '"Valay Parikh"' showing total 80 results

Search Constraints

Start Over You searched for: Author "Valay Parikh" Remove constraint Author: "Valay Parikh"
80 results on '"Valay Parikh"'

Search Results

2. Impact of ultra‐conservative ICD programming in patients with LVADs: Avoiding potentially unnecessary tachy‐therapies

3. Electromagnetic interference from left ventricular assist devices detected in patients with implantable cardioverter‐defibrillators

4. Outcomes of junctional ectopic tachycardia ablation in adult population—a multicenter experience

5. Economics and laboratory efficiency of atrial fibrillation ablation

6. Safety and outcomes of catheter ablation for atrial fibrillation in adults with congenital heart disease: A multicenter registry study

7. Intramural anterolateral mitral annular idiopathic ventricular tachycardia successfully ablated from the atrium

8. Temporal relationships between esophageal injury type and progression in patients undergoing atrial fibrillation catheter ablation

9. Same-Day Discharge after Cryoballoon Ablation of Atrial Fibrillation: A Multicenter Experience

11. Feasibility, safety, and efficacy of a novel preshaped nitinol esophageal deviator to successfully deflect the esophagus and ablate left atrium without esophageal temperature rise during atrial fibrillation ablation: The DEFLECT GUT study

12. Management of cardiac implantable electronic devices in the presence of left ventricular assist devices

13. Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies

14. B-PO05-100 SAFETY AND EFFICACY OF CRYOBALLOON ABLATION OF ATRIAL FIBRILLATION IN PATIENTS WITH MECHANICAL MITRAL VALVE

15. Systemic Octreotide Therapy in Prevention of Gastrointestinal Bleeds Related to Arteriovenous Malformations and Obscure Etiology in Atrial Fibrillation

16. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry

17. An interesting case of reverse electrical remodeling of the left atrium after radiofrequency ablation

18. Dofetilide Initiation and Implications of Deviation From the Standard Protocol – A Real World Experience

19. Myocarditis Causing Premature Ventricular Contractions

20. Outcomes of junctional ectopic tachycardia ablation in adult population-a multicenter experience

21. Exclusion of electrical and mechanical function of the left atrial appendage in patients with persistent atrial fibrillation: differences in efficacy and safety between endocardial ablation vs epicardial LARIAT ligation (the EXCLUDE LAA study)

22. Peri-procedural use of direct anticoagulation agents during cardiac device implantation: vitamin K antagonists vs direct oral anticoagulants

23. Long-term clinical outcomes from real-world experience of left atrial appendage exclusion with LARIAT device

24. Five years of keeping a watch on the left atrial appendage—how has the WATCHMAN fared?

25. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention

26. Gender, Racial, and Health Insurance Differences in the Trend of Implantable Cardioverter-Defibrillator (ICD) Utilization: A United States Experience Over the Last Decade

27. Abstract 17325: Initial False Positive Episodes and Outcomes of Programming Changes With a Novel Implantable Loop Recorder

28. Safety and Efficacy of Inpatient Initiation of Dofetilide versus Sotalol for atrial fibrillation

29. Abstract 21359: Safety of Repeat Radiofrequency Ablation in Atrial Fibrillation Patients With Moderate Pulmonary Vein Stenosis

30. Abstract 20927: Use of a Novel Pre-Shaped Nitinol Esophageal Deviator (EsoSure®) to Successfully Ablate the Left Atrium Without Esophageal Temperature Rise During Atrial Fibrillation Ablation: The DEFLECT GUT Study

31. Leaks after left atrial appendage ligation with Lariat device: Incidence, pathophysiology, clinical implications and methods of closure- A case based discussion

32. Early feasibility of hypoglossal nerve upper airway stimulator in patients with cardiac implantable electronic devices and continuous positive airway pressure-intolerant severe obstructive sleep apnea

33. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016

34. Corrigendum to 'Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials' [Int. J. Cardiol. (2017) 137-144]

35. Replacing warfarin with a novel oral anticoagulant: Risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study)

36. Recordings of diaphragmatic electromyograms during cryoballoon ablation for atrial fibrillation accurately predict phrenic nerve injury

37. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: Insights from the National Health and Nutrition Examination Survey-III

38. IMPACT OF ULTRA-CONSERVATIVE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR PROGRAMMING IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES: AVOIDING UNNECESSARY TACHY-THERAPIES

39. Impact of Radiofrequency Ablation of Atrial Fibrillation on Pulmonary Vein Cross Sectional Area: Implications for the Diagnosis of Pulmonary Vein Stenosis

40. Esophageal Temperature Monitoring During Radiofrequency Ablation of Atrial Fibrillation: A Meta-Analysis

41. Percutaneous left atrial appendage closure: current state of the art

43. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry

44. Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials

45. Clinical Application of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention for Stable Coronary Artery Disease

46. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry

47. Unusual Presentation of Lemierre Syndrome

48. CORRELATION OF EKG BASED SITE OF ORIGIN OF VENTRICULAR ARRHYTHMIAS WITH SITE OF INFLAMMATION ON FDG-PET SCAN IN PATIENTS WITH ARRHYTHMOGENIC INFLAMMATORY CARDIOMYOPATHY

49. RISK OF LEAD DISLODGEMENT WITH CATHETER ABLATION IN PATIENTS WITH RECENTLY IMPLANTED CARDIAC IMPLANTABLE ELECTRONIC DEVICE: A FIVE-YEAR EXPERIENCE

50. LEFT ATRIAL APPENDAGE OCCLUSION DEVICE EMBOLIZATION (LAAODE): UNDERSTANDING THE TIMING, MECHANISM AND OUTCOMES

Catalog

Books, media, physical & digital resources